Drugs / autogenous dentin graft
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT06853392 | Sep 2023 → Apr 2024 | bone resorption disease | Faculty of Dental Medicine for Girls | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT07362394 | Jun 2026 → Nov 2027 expected | disease of bone structure, impacted teeth, multiple, tooth hard tissue disease | National University of Malaysia | Not yet recruiting | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04131894 Comparator | Dec 2016 → Apr 2018 | disease of bone structure | Bahçeşehir University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | autogenous dentin graft | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06853392 ↗ |
| Known as | Autologous dentin graft | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07362394 ↗ |